TOPRAK, Ç. Et Al. 2023. Methylation of RARß is a New Clinical Biomarker for Treatment in Higher‑grade Gliomas. Neurological Sciences and Neurophysiology , vol.40, no.3 , 152-159.

TOPRAK, Ç., ATLI, E. İ., & Kalkan, R., (2023). Methylation of RARß is a New Clinical Biomarker for Treatment in Higher‑grade Gliomas. Neurological Sciences and Neurophysiology , vol.40, no.3, 152-159.

TOPRAK, ÇİĞDEM, EMİNE İKBAL ATLI, And Rasime Kalkan. "Methylation of RARß is a New Clinical Biomarker for Treatment in Higher‑grade Gliomas," Neurological Sciences and Neurophysiology , vol.40, no.3, 152-159, 2023

TOPRAK, ÇİĞDEM Et Al. "Methylation of RARß is a New Clinical Biomarker for Treatment in Higher‑grade Gliomas." Neurological Sciences and Neurophysiology , vol.40, no.3, pp.152-159, 2023

TOPRAK, Ç. ATLI, E. İ. And Kalkan, R. (2023) . "Methylation of RARß is a New Clinical Biomarker for Treatment in Higher‑grade Gliomas." Neurological Sciences and Neurophysiology , vol.40, no.3, pp.152-159.

@article{article, author={ÇİĞDEM TOPRAK Et Al. }, title={Methylation of RARß is a New Clinical Biomarker for Treatment in Higher‑grade Gliomas}, journal={Neurological Sciences and Neurophysiology}, year=2023, pages={152-159} }